Fibroadenoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{HL}} | {{CMG}} {{AE}} {{HL}} | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of fibroadenoma are obesity, eostrogen replacement therapy, and nulliparity. | |||
==Risk Factors== | ==Risk Factors== | ||
* The table below lists the risk factors involved in the development of fibroadenoma: | * The table below lists the risk factors involved in the development of fibroadenoma: | ||
Revision as of 16:01, 1 February 2016
|
Fibroadenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fibroadenoma risk factors On the Web |
|
American Roentgen Ray Society Images of Fibroadenoma risk factors |
|
Risk calculators and risk factors for Fibroadenoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
Common risk factors in the development of fibroadenoma are obesity, eostrogen replacement therapy, and nulliparity.
Risk Factors
- The table below lists the risk factors involved in the development of fibroadenoma:
| Risk Factor | Description |
|---|---|
| Obesity | An increase in BMI is correlated with an increased risk of fibroadenoma development. |
| Estrogen replacement therapy | Estrogen replacement therapy is correlated with an increased risk of fibroadenoma development. |
| Pregnancy | Nulliparous women are associated with an increased risk of fibroadenoma development. Whereas multiparous women are associated with a lower risk of fibroadenoma development. |
| Contraception | The use of oral contraceptive pills is associated with a lower risk of fibroadenoma development as compared to other contraceptive methods. |
| Socioeconomic status | A higher socioeconomic status is correlated with an increased risk of fibroadenoma development. |